UnknownPhase 2

Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)

Greece52 participantsStarted 2007-09

Plain-language summary

The purpose of this study is to investigate the role of EMS as a preventive and therapeutic tool of CIPNM. The investigators hypothesized that EMS will prevent the development of CIPNM or have a beneficial role as a therapeutic means in case of CIPNM appearance.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients admitted in ICU of Evaggelismos Hospital Exclusion Criteria: * age \< 18 years * pregnancy * pre-existing neuromuscular disease (e.g. Gravis) * connective tissue disease * fractures or skin lesions that do not allow the implementation of EMS * BMI \> 35 kg/m2 * brain death * terminal disease * length of stay \< 48 hours * presence of pacemaker

What they're measuring

Diagnosis of CIPNM

Timeframe: June 2009

Trial details

NCT IDNCT00882830

SponsorUniversity of Athens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-06

View on ClinicalTrials.gov More Critical Illness Polyneuromyopathy (CIPNM) trials